Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 1, 2011

Sanofi to top sales league, ousting Pfizer

Sanofi is set to knock Pfizer off the top of the pharmaceutical sales table next year, according to EvaluatePharma sales forecasts.

By Liam Stoker

Sanofi is set to knock Pfizer off the top of the pharmaceutical sales table next year, according to EvaluatePharma sales forecasts.

Aided by acquisitions including US biotechnology company Genzyme, Sanofi is expected to hold the top spot until at least 2016, as Pfizer suffers from the patent expiry of its Lipitor medication.

Although Sanofi medications such as Plavix, Lovenox and Taxotere face substantial generic competition, sales of drugs originally belonging to Genzyme such as Cerezyme and Lumizyme/Myozyme are likely to offset any sales losses.

EvaluatePharma has also predicted Novartis pipping Pfizer to second place, buoyed by the performance of Gilenya, used to treat multiple sclerosis, and Tasigna, used in the treatment of chronic myeloid leukaemia.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU